SCHEMBL889796

SCHEMBL889796

COc1ccccc1P(Cl)c1ccccc1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.55
CA2 P00918 3/20 0.55
CA7 P43166 2/20 0.55
CA9 Q16790 2/20 0.55
CA12 O43570 1/20 0.55
CA4 P22748 1/20 0.55
CA14 Q9ULX7 1/20 0.55
ALDH1A1 P00352 5/20 0.44
TP53 P04637 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
TSHR P16473 1/20 0.44
ADRA2B P18089 1/20 0.44
PTGS1 P23219 1/20 0.44
MAPK1 P28482 2/20 0.43
HTT P42858 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ENPP2 Q13822 1/20 0.41
ORAI1 Q96D31 1/20 0.40
ORAI2 Q96SN7 1/20 0.40
ORAI3 Q9BRQ5 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12311876 0.90 CA1 (0.44) CA1CA2CA7CA9CA12
SCHEMBL17307073 0.88 CA1 (0.55) CA1CA2CA7CA9CA12
SCHEMBL2154356 0.87 CA1 (0.46) CA1CA2CA7CA9CA12
SCHEMBL2230609 0.86 CA1 (0.55) CA1CA2CA7CA9CA12
SCHEMBL30837263 0.86 CA1 (0.55) CA1CA2CA7CA9CA12
SCHEMBL15711151 0.86 CA1 (0.44) CA1CA2CA7CA9CA12
SCHEMBL28896064 0.82 KDM4E (0.54) CA1CA2CA7CA9CA12
SCHEMBL29405044 0.80 CA1 (0.60) CA1CA2CA7CA9CA12
SCHEMBL50148 0.80 CA1 (0.60) CA1CA2CA7CA9CA12
SCHEMBL10414766 0.80 CA1 (0.60) CA1CA2CA7CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113292732-B Modified ethylene-methyl acrylate copolymer and preparation method and application thereof 安徽清澜新材料科技有限公司 2022-06-03 CN claimed
US-20250101143-A1 CATALYST FOR OLEFIN POLYMERIZATION AND PRODUCTION METHOD FOR OLEFIN-BASED POLYMER THE UNIVERSITY OF TOKYO (JP) 2025-03-27 US disclosed
EP-4442714-A1 CATALYST FOR OLEFIN POLYMERIZATION AND PRODUCTION METHOD FOR OLEFIN-BASED POLYMER The University of Tokyo (JP) 2024-10-09 EP disclosed
US-12107264-B2 Anode active material comprising metal phosphide coating on surface of carbon material, preparation method therefor, nonaqueous lithium secondary battery comprising anode active material, and manufacturing method therefor KOREA ELECTROTECHNOLOGY RESEARCH INSTITUTE (KR) 2024-10-01 US disclosed
CN-115926027-B Supported catalyst and preparation method thereof, and preparation method of polyolefin composite material 中国科学技术大学 2024-08-23 CN disclosed
CN-117986304-A Complex, catalyst system containing complex and use of catalyst system 东华大学 2024-05-07 CN disclosed
CN-117659087-A Binuclear metal complex containing NP structure, preparation method and application thereof 中化学科学技术研究有限公司 2024-03-08 CN disclosed
CN-114933613-B Preparation of PNNP ligand, ethylene oligomerization catalyst and application thereof 万华化学集团股份有限公司 2024-02-27 CN disclosed
US-11833495-B2 Heterobimetallic catalysts and site-differentiated ligands for preparation thereof UNIVERSITY OF HOUSTON SYSTEM (US) 2023-12-05 US disclosed
US-11833495-B2 Heterobimetallic catalysts and site-differentiated ligands for preparation thereof UNIVERSITY OF HOUSTON SYSTEM (US) 2023-12-05 US disclosed
EP-1885733-A1 FERROCENYL LIGANDS, PRODUCTION AND USE THEREOF Solvias AG (CH) 2008-02-13 EP disclosed
WO-2007104690-A1 ASYMMETRIC CATALYTIC HYDROGENATION OF PROCHIRAL KETONES AND ALDEHYDES SOLVIAS AG (CH) 2007-09-20 WO disclosed
US-7250519-B2 Method for the production of arylamines MERCK PATENT GMBH (DE) 2007-07-31 US disclosed
EP-1442007-B1 METHOD FOR THE PRODUCTION OF ARYLAMINES MERCK PATENT GMBH (DE) 2006-11-29 EP disclosed
WO-2006117369-A1 FERROCENYL LIGANDS, PRODUCTION AND USE THEREOF SOLVIAS AG (CH) 2006-11-09 WO disclosed
US-20050054854-A1 Method for the production of arylamines MERCK PATENT GMBH (DE) 2005-03-10 US disclosed
EP-1442007-A1 METHOD FOR THE PRODUCTION OF ARYLAMINES Covion Organic Semiconductors GmbH (DE) 2004-08-04 EP disclosed
WO-2003037844-A1 METHOD FOR THE PRODUCTION OF ARYLAMINES COVION ORGANIC SEMICONDUCTORS GMBH (DE) 2003-05-08 WO disclosed
EP-0987271-A1 An optically active diaminophosphine ligand-transition metal complex Ajinomoto Co., Inc. (JP) 2000-03-22 EP disclosed
US-4874897-A REACTING ALKOXYPHENYL GRIGNARD WITH PHOSPHORUS TRIHALIDE, ALKALI METAL HYDRIDE, HYDROLYZING, REACTING WITH DIHALOPROPANE SHELL OIL COMPANY (US) 1989-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054854-A1 Method for the production of arylamines DDT, PDS5A, KMO CA1 3320/4885CA2 2058/4885CA7 1417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.